CASTELLI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 30.424
EU - Europa 15.101
AS - Asia 9.232
AF - Africa 144
Continente sconosciuto - Info sul continente non disponibili 38
OC - Oceania 32
SA - Sud America 30
Totale 55.001
Nazione #
US - Stati Uniti d'America 30.290
UA - Ucraina 5.026
CN - Cina 4.602
IT - Italia 3.034
DE - Germania 2.017
SG - Singapore 1.969
PL - Polonia 1.331
HK - Hong Kong 1.283
FI - Finlandia 1.096
TR - Turchia 876
IE - Irlanda 852
GB - Regno Unito 769
FR - Francia 358
SE - Svezia 346
IN - India 284
CA - Canada 128
BE - Belgio 75
VN - Vietnam 64
ID - Indonesia 53
MU - Mauritius 52
RU - Federazione Russa 52
CZ - Repubblica Ceca 41
EU - Europa 38
NL - Olanda 29
AU - Australia 28
IR - Iran 28
BR - Brasile 16
BF - Burkina Faso 14
GH - Ghana 13
JP - Giappone 13
RO - Romania 12
ES - Italia 10
ET - Etiopia 9
CI - Costa d'Avorio 8
AT - Austria 7
CH - Svizzera 7
KR - Corea 7
SA - Arabia Saudita 7
NG - Nigeria 6
PH - Filippine 6
ZA - Sudafrica 6
IL - Israele 5
EE - Estonia 4
GF - Guiana Francese 4
HR - Croazia 4
MA - Marocco 4
MK - Macedonia 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
TN - Tunisia 4
TZ - Tanzania 4
UG - Uganda 4
ZM - Zambia 4
AR - Argentina 3
BD - Bangladesh 3
BG - Bulgaria 3
CM - Camerun 3
KE - Kenya 3
MD - Moldavia 3
MM - Myanmar 3
MX - Messico 3
SI - Slovenia 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CD - Congo 2
CL - Cile 2
CY - Cipro 2
EC - Ecuador 2
HU - Ungheria 2
IQ - Iraq 2
JO - Giordania 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MG - Madagascar 2
PK - Pakistan 2
AL - Albania 1
AO - Angola 1
BJ - Benin 1
BO - Bolivia 1
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
EG - Egitto 1
GE - Georgia 1
GR - Grecia 1
IM - Isola di Man 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LT - Lituania 1
MY - Malesia 1
NA - Namibia 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
Totale 54.994
Città #
Jacksonville 3.633
Fairfield 3.589
Woodbridge 2.880
Chandler 2.141
Wilmington 1.993
Ashburn 1.888
Houston 1.720
Princeton 1.603
Singapore 1.573
Cambridge 1.467
Ann Arbor 1.464
Seattle 1.411
Warsaw 1.327
Hong Kong 1.275
Nanjing 1.226
Dublin 843
Istanbul 758
New York 683
Beijing 521
Helsinki 488
Nanchang 423
Des Moines 357
Brescia 311
Shenyang 309
Hebei 264
Changsha 262
San Diego 233
Milan 229
Tianjin 218
Dearborn 202
Jinan 198
Jiaxing 195
Shanghai 166
Munich 149
Kunming 140
Hangzhou 126
Verona 116
Boardman 110
Kocaeli 94
Mcallen 83
Ningbo 77
London 76
Brussels 73
Zhengzhou 69
Lanzhou 67
Los Angeles 64
Romola 61
Toronto 59
Dong Ket 58
Norwalk 56
Rome 56
San Francisco 56
Lancaster 48
Jakarta 46
Taizhou 45
Haikou 41
Montréal 39
Washington 39
Pune 36
Brno 35
Guangzhou 34
Leawood 34
Bologna 32
Augusta 30
Taiyuan 30
Changchun 29
Kilburn 29
Auburn Hills 26
Falls Church 25
San Mateo 25
Fuzhou 24
Bergamo 21
Hefei 20
Lappeenranta 20
Monmouth Junction 20
Orange 20
Santa Clara 18
Ardabil 16
Redmond 15
Redwood City 15
Napoli 14
Ouagadougou 13
Accra 12
Cazzago San Martino 12
Dallas 12
Florence 12
Hanover 12
Indiana 12
Melbourne 12
Torino 12
Acton 11
Chiswick 11
Ottawa 11
Tokyo 11
Westminster 11
Hounslow 10
Moscow 10
Catania 9
Chicago 9
Mountain View 9
Totale 38.477
Nome #
Influence of maternal CD4+ levels on the predictive value of virus load mother-to-child transmission of HIV type 1 (HIV-1) 375
The impact of antiretroviral therapy on iron homeostasis and inflammation markers in HIV-infected patients with mild anemia 235
BACTERIAL BLOOD STREAM INFECTIONS NEGATIVELY IMPACT ON OUTCOME OF PATIENTS TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION: 6 YEARS SINGLE-CENTRE EXPERIENCE 233
Cos’è la Medicina Tropicale 224
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 222
Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study 216
Miscarriage following dengue virus 3 infection in the first six weeks of pregnancy of a dengue virus-naive traveller returning from Bali to Italy, April 2016 205
Proceedings of the IV Congress of the University Network for Development Cooperation (CUCS) “Rinforzare il capitale umano nei paesi a risorse limitate: health and wealth for all by the year 2030” 197
Arboviral and other illnesses in travellers returning from Brazil, june 2013 to may 2016: Implications for the 2016 olympic and paralympic games 196
Hcverso1 and 2: Faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection 184
An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia 175
The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: Results from the Italian MASTER Cohort 171
Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study. 167
Impact of the SARS Coronavirus 2 epidemic on tuberculosis treatment outcome, Northern Italy 166
Effectiveness of routine lumbar puncture in patients with HIV-associated Dementia (HAD) receiving suppressive antiretroviral treatment 165
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 160
Burden of Non-AIDS-Defining and Non-Virus-Related Cancers Among HIV-Infected Patients in the Combined Antiretroviral Therapy Era. 159
Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study 149
Malaria chemoprophylactic recommendations for immigrants to Europe, visiting relatives and friends - a Delphi method study 144
Cohort profile: Standardized management of antiretroviral therapy cohort (MASTER cohort) 140
Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy 140
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 139
Towards tuberculosis elimination: An action framework for low-incidence countries 138
Prevalence of integrase strand transfer inhibitors (InSTIs) resistance mutations in InSTIs-naive and -experienced HIV-1 infected patients: a single Center experience 138
A case of melioidosis probably acquired by inhalation of dusts during a helicopter flight in a healthy traveler returning from singapore 134
Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy 134
Imported malaria in an HIV-positive traveler. A case-report with a fatal outcome 132
Screening for Neurocognitive Impairment in HIV-Infected Individuals at First Contact after HIV Diagnosis: The Experience of a Large Clinical Center in Northern Italy 130
Sustained virological response to peginterferon therapy in patients infected with HCV (genotypes 2 and 3), with or without HIV 129
Clinical and Immunological outcomes according to adherence to first-line HAART in a urban and rural cohort of HIV-infected patients in Burkina Faso, West Africa 128
Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: A substudy of the NEAT001/ANRS143 randomised trial 128
Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected Patients 126
Incidence of cardiovascular events in HIV-positive patients compared to general population over the last decade: a population-based study from 2000 to 2012 125
Risk of congenital toxoplasmosis in women with low or indeterminate anti-Toxoplasma IgG avidity index in the first trimester of pregnancy: an observational retrospective study 125
Long-Term Response in Patients Receiving Haart Including Nelfinavir: Experience from Two Italian Centers 123
Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmaco-economic implications in a population-based setting 123
Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: Routine evidence from the Italian MASTER Cohort 122
Genotype resistance profiles in patients failing an NNRTI-containing regimen, and modifications after stopping NNRTI therapy 121
The prognostic role of systemic inflammatory markers on HIV-infected patients with non-Hodgkin lymphoma, a multicenter cohort study 121
Key Questions in antiretroviral therapy: Italian Consensus Workshop (2005) 120
Variability in malaria prophylaxis prescribing across Europe: a Delphi method analysis 120
CD11b expression identifies CD8(+)CD28(+) T lymphocytes with phenotype and function of both naive/memory and effector cells 119
Accidental and transfusion malaria in Italy 118
Migration Medicine: the Challenge of Tuberculosis 117
Advances in the treatment of malaria 117
Breast cancer among human immunodeficiency virus (HIV)-infected patients: the experience in Brescia, Northern Italy. 116
ABDOMINAL AORTITIS AND ANEURYSM IMPENDING RUPTURE DURING PNEUMOCOCCAL MENINGITIS 116
Aetiology of acute gastro-enteritis in children at Saint Camille Medical Centre, Ouagadougou, Burkina Faso 115
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 115
Vaccination against enterotoxigenic Escherichia coli, a cause of travelers' diarrhea 114
STI epidemics in the Indian Ocean Region: can the phase be assessed? 114
Trigger-oriented HIV testing at Internal Medicine hospital Departments in Northern Italy: an observational study (Fo.C.S. Study) 113
Clinical Care of Hematological Patients in a Bone Marrow Transplant Unit: Do Human Resources Influence Infection Incidence? 113
Bcl-2 expression is moderately correlated with long-term variability of CD4+ T-cell increase under successful highly active antiretroviral therapy 113
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART 113
Prevalence of non-B HIV-1 subtypes in North Italy and analysis of transmission clusters based on sequence data analysis 113
HYALURONIC ACID AND LIVER STIFFNESS REDUCTION IN HIV-HEPATITIS-C (HCV) COINFECTED PATIENTS TREATED WITH A CCR5 INHIBITOR MARAVIROC (MVC) IN A RANDOMIZED CONTROLLED TRIAL (MAICOL STUDY-48-WEEK ANALYSIS) 112
Lung cancer in HIV-infected patients: the experience in Brescia from 1999 to 2009 112
Caratteri generali dei protozoi patogeni per l’uomo e delle infezioni protozoarie umane 111
Depressive disorders and personality variables in HIV positive and negative intravenous drug-users 111
Long-lasting humoral immune response induced in HIV-1-infected patients by a synthetic peptide (AT20) derived from the HIV-1 matrix protein p17 functional epitope. 111
Algorithm based management of pneumonia in HIV-1 infected patients 110
Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients 110
Vaccine preventable diseases in returned international travelers: results from the Geosentinel Surveillance Network 109
Active tuberculosis case finding among pregnant women: A pilot project in Burkina Faso 109
Non-typhoidal Salmonella aortitis 109
Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference 109
Reduction of mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso 108
Higher short-term virologic efficacy of three-class versus two-class highly active antiretroviral salvage therapy in Hiv-infected patients 108
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group. 108
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study 108
Consequences of the COVID-19 pandemic on the continuum of care in a cohort of people living with HIV followed in a single center of Northern Italy 108
Vaccine Preventable Diseases in returned international Travelers: results from the Geosentinel Surveillance Network 107
Neutrophil to Lymphocyte Ratio and Cardiovascular Disease Incidence in HIV-Infected Patients: A Population-Based Cohort Study 107
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 107
Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of northern Italy,1999-2009 107
Prevalence of anti-poliovirus type 1, 2 and 3 antibodies in unvaccinated Italian travelers 106
Epidemiology of malaria in endemic areas 106
Prevalence and determinants of Herpes simplex virus type 2 infection in a cohort of HIV-positive individuals in Italy 105
Antenatal Screening for Mother to Child Infections in Immigrants and Residents: The Case of Toxoplasmosis in Northern Italy 105
A Case of Rickettsia felis Infection Imported from Nepal 105
The burden of chronic diseases and cost-of-care in subjects with HIV infection in a Health District of Northern Italy over a 12-year period compared to that of the general population 105
Dermatologic conditions of the ill returned traveler: an analysis from the GeoSentinel Surveillance Network 104
Epidemiological features and case-management practices of imported malaria in northern Italy 104
New italian guidelines for malaria prophylaxis in travellers to endemic areas 104
Systemic Inflammation-Based Biomarkers and Survival in HIV-Positive Subject with Solid Cancer in an Italian Multicenter Study 104
Colitis during new direct-acting antiviral agents (DAAs) therapy with sofosbuvir, simeprevir and ribavirin for genotype 1b hepatitis C 104
Effectiveness of kidney transplantation in HIV-infected recipients under combination antiretroviral therapy: a single-cohort experience (Brescia, Northern Italy) 104
Characteristics of schistosomiasis in travelers reported to the GeoSentinel Surveillance Network 1997-2008 103
Multicenter EuroTravNet/GeoSentinel study of travel-related infectious diseases in Europe. 103
Filariasis in travelers presenting to the Geosentinel Surveillance Network 103
Patterns of illness in travelers visiting Mexico and Central America: the GeoSentinel experience. 103
Point-of-care screening, prevalence, and risk factors for hepatitis B infection among 3,728 mainly undocumented migrants from Non-EU countries in northern Italy 103
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 103
Screening for active and latent tuberculosis among asylum seekers in Italy: A retrospective cohort analysis 103
Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: A MASTER cohort study 103
Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infection 102
Preterm delivery risk in migrants in Italy. An observational prospective study 102
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy 102
Louse-borne relapsing fever in a refugee from Mali 102
Totale 12.974
Categoria #
all - tutte 314.947
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 314.947


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.132 0 0 0 0 567 1.395 985 1.381 707 1.842 342 913
2020/20219.967 133 1.252 433 1.169 352 1.217 300 1.170 1.528 1.012 1.101 300
2021/20225.848 309 1.166 114 395 89 328 250 459 331 694 506 1.207
2022/20236.003 919 106 104 597 541 1.598 18 623 927 50 232 288
2023/20245.254 378 176 397 331 222 926 176 205 1.329 69 108 937
2024/20253.407 121 74 132 1.544 1.536 0 0 0 0 0 0 0
Totale 56.031